Live attenuated vaccine (USAMRIID/USAMRMC)

N/A

Report date: 2025/08/12 20:00:05

Base Information

Drug NameLive attenuated vaccine (USAMRIID/USAMRMC)
Drug Alias NameVEE Vaccine (USAMRIID/USAMRMC)Live attenuated vaccine (US Army Medical Research Institute of Infectious Diseases/US Army Medical Research and Materiel Command)TC-83NDBR-102
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEncephalomyelitis, Venezuelan Equine
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUS Army Medical Research Institute of Infectious DiseasesUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesU.S. Army Medical Research And Development Command
Active IndicationsN/A
Inactive IndicationsEncephalomyelitis, Venezuelan Equine

Other Information

ATC CodeN/A
Related LinksN/A